Quantcast

Promega to Offer Leading Transfection Tool FuGENE® 6

February 3, 2011

Promega and Fugent recently signed a supply agreement that establishes Promega as a provider of the leading transfection tool FuGENE® 6.

Madison, WI (PRWEB) February 2, 2011

Promega Corporation and Fugent LLC recently signed a supply agreement that establishes Promega as a provider of the leading transfection tool FuGENE® 6. This agreement ensures that researchers will continue to have access to the FuGENE® transfection reagents they have always used in their daily research. This expands on the existing Promega/Fugent agreement for supply of the FuGENE® HD Transfection reagent.

For over 13 years Fugent has been the manufacturer of FuGENE® 6 transfection reagent, which has nearly 10,000 citations in scientific literature to date.* “FuGENE® 6 and our new transfection reagent FuGENE® HD are designed, developed and exclusively manufactured by Fugent LLC” says Vladimir Gurevich, President of Fugent LLC. Both FuGENE® 6 and FuGENE® HD demonstrate very high transfection efficiency with low toxicity and they have very simple protocols. FuGENE® transfection supports a breadth of Promega technologies including luciferase technologies used for for cell-based assays.

“FuGENE® 6 is a leading transfection solution with trusted performance in a variety of cell model systems. Promega now has leading transfection tools for working with a myriad of biological systems, from standard cells and cancer models to primary and stem cells.” says Kevin Kopish, Promega Strategic Marketing Manager. “This is also a perfect complement to Promega cell-based assays, especially with our Glo technology offerings.”

Please visit http://www.promega.com/fugene for the latest information and to be contacted when FuGENE® 6 Transfection reagent is available from Promega.

FuGENE® is a registered trademark of Fugent, LLC, USA.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit http://www.promega.com.

*Per High Wire Search

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/02/prweb5028014.htm


Source: prweb



comments powered by Disqus